Become an ICS Member today to watch
Sign in to watch
You do not have permission to view this video
ICS members can access all the meeting webcasts
Yasuhiko Igawa ICS Chair
Pradeep Tyagi ICS Chair
Martijn Smits ICS Chair
09:00
#193 Can supraspinal functional connectivity during natural bladder filling in overactive bladder differentiate between full versus empty bladder states
Presenter: Rose Khavari, United States
Bayer A1, High R2, Santoso A3, Aazhang B1, Khavari R21. Rice University, 2. Houston Methodist, 3. KU Leuven Basic Science, Overactive Bladder, Imaging, Male, Female
09:07
#194 Refining Brainstem-Cortical Connectivity During Natural Bladder Filling in Multiple Sclerosis Patients with Overactive Bladder
Bayer A1, Santoso A2, Lozano V3, High R3, Aazhang B1, Khavari R31. Rice University, 2. KU Lueven, 3. Houston Methodist Basic Science, Overactive Bladder, Multiple Sclerosis, Female, Imaging
09:15
#195 Akkermansia muciniphila Drives Viscero-Visceral Crosstalk via 5-HT3aR-Mediated Sensitization of Dichotomizing Gut-Bladder Neurons
Presenter: Qi Sun, China
Sun Q1, Gao Y1, Zheng J1, Cheng B1, Wu P11. Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China Overactive Bladder, Animal Study, Basic Science, Pathophysiology, Pre-Clinical testing
09:22
#196 Therapeutic and Preventive Effects of Acupuncture on Cyclophosphamide-Induced Overactive Bladder in Rats
Presenter: Qiongqiong Liu, China
Liu Q1, Ma D1, Chen Y1, PANG R11. Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China Overactive Bladder, Animal Study, Molecular Biology
09:30
#197 Efficacy and safety of vibegron in the very elderly (aged ≥ 80 years) with overactive bladder: A prospective study (HOKUTO 2)
Presenter: Hiroshi Shimura, Japan
Shimura H1, Aikawa J1, Kakibuchi Y1, Mochizuki T1, Kira S1, Mitsui T11. University of Yamanashi Graduate School of Medical Sciences Overactive Bladder, Prospective Study, Questionnaire
09:37
#198 Retinal safety of mirabegron in patients with overactive bladder
Presenter: Blayne Welk, Canada
Welk B1, McArthur E2, Armstrong J1, Hutnik C11. Western University, 2. ICES Overactive Bladder, Pharmacology, Incontinence
09:45
#199 Nervous system disorders related to anticholinergics and β3-agonists use: findings from the European Union Drug Regulatory Authorities (EUDRA) registry
Presenter: Daniele Bianchi, Italy
Bianchi D1, Rosato E1, Fanara F1, Finazzi Agrò E11. Tor Vergata University, Rome, Italy Detrusor Overactivity, Incontinence, Overactive Bladder, Urgency Urinary Incontinence, Urgency/Frequency
09:52
#200 Parasacral transcutaneous electrical nerve stimulation versus sham and mirabegron for female overactive bladder: a single-blind randomized controlled trial with pelvic floor muscle training
Presenter: Parvin Bastani, Iran
Bastani P1, Sattarpour R1, Hajebrahimi S2, Mostafaei H21. bastanialamdarip@gmail.com, 2. Research Center for Evidence-Based Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Pelvic Floor, Overactive Bladder, Pharmacology
10:00
#201 Repetitive Transcranial Magnetic Stimulation for Idiopathic Overactive Bladder: A Pilot Trial
Presenter: Kelly Ieong
Ieong K1, Fendereski K1, Salazar B1, Khavari R1, High R11. Houston Methodist Hospital Overactive Bladder, Neuromodulation, Incontinence
10:07
#202 Next-gen neuromodulation leveraging EMG to refine stimulation paradigms
Presenter: Kenneth Peters, United States
Peters K1, Sanchez R1, Zwaans B1, Kennedy A1, Abdelhady M2, Gilleran J1, Padmanabhan P11. Corewell Health William Beaumont University Hospital, 2. Oakland University William Beaumont School of Medicine Overactive Bladder, Retrospective Study, Neuromodulation
10:15
#203 To EMG or not to EMG, the neuromodulation dilemma
Peters K1, Sanchez R1, Zwaans B1, Kennedy A1, Abdelhady M2, Gilleran J1, Padmanabhan P11. Corewell Health William Beaumont University Hospital, 2. Oakland University William Beaumont School of Medicine Neuromodulation, Overactive Bladder, Outcomes Research Methods
10:22
#204 PNE SUCCESS AFTER NEW LEAD INTRODUCTION: TEN YEARS OF DATA FROM A SINGLE INSTITUTION EXPERIENCE
Presenter: Howard B. Goldman, United States
D'Amico M1, El Hussein M1, Slopnick E1, Vasavada S1, Goldman H1, Albakr A11. Cleveland Clinic Foundation Incontinence, Neuromodulation, Retrospective Study